Minireviews
Copyright ©The Author(s) 2024.
World J Transplant. Mar 18, 2024; 14(1): 90277
Published online Mar 18, 2024. doi: 10.5500/wjt.v14.i1.90277
Table 1 Etiology and classification of thrombotic microangiopathies
Primary TMAs
Shiga toxin-producing E. Coli-associated HUS
Thrombotic thrombocytopenic purpura
Atypical HUS or complement-mediated
Secondary TMAs
Infections including viral, fungal, and bacterial
Drugs including immunosuppressants and chemotherapeutic agents
Autoimmune diseases
Malignant hypertension
Malignancy
Metabolic defects
Pregnancy
Transplantation, both hematopoietic stem cell transplantation and solid organ transplantation
Disseminated intravascular coagulation
Radiation